Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-14-003164
Filing Date
2014-05-19
Accepted
2014-05-19 17:15:16
Documents
1
Period of Report
2014-05-07

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2746
  Complete submission text file 0001062993-14-003164.txt   4278
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 51 W 52ND STREET 7TH FLOOR NEW YORK NY 10091
Business Address
FAVUS ELLIOT (Reporting) CIK: 0001608022 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51652 | Film No.: 14855518